Internal Medicine · Fort Payne, AL
NPI
1023063922
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2202 Jordan Road SW, Suite 500
Fort Payne, AL, 35968
Phone (256) 844-2825
Groups this clinician bills Medicare through
Medicare paid, 2024
$155K
2,545 services
Medicare patients, 2024
502
Average age 76
Drug cost, 2024
$2.7M
26,876 prescriptions
Company payments, 2025
$1,009
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carmelo C Mendiola was code 99213 (office e&m - established), 675 times for 335 patients. In total Carmelo C Mendiola billed 2,545 services in 42 codes, and Medicare paid $155K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-01-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 675 | 335 | $47.54 | $32K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 297 | 297 | $118.79 | $35K |
| 90970 ESRD Related Services (not dialysis) | Office | 204 | 14 | $6.96 | $1,421 |
| 99214 Office E&M - Established | Office | 165 | 130 | $81.49 | $13K |
| 90961 ESRD Related Services (not dialysis) | Office | 144 | 18 | $214.91 | $31K |
| G0008 Administration of influenza virus vaccine | Office | 143 | 138 | $24.50 | $3,504 |
| 90656 Vaccine Product | Office | 133 | 133 | $21.90 | $2,913 |
| 81002 Clinical Chemistry | Office | 122 | 73 | $3.41 | $416 |
| 96372 Injection Administration | Office | 103 | 70 | $8.18 | $843 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 82 | 68 | $0.07 | $5.82 |
| 99442 Telephone Services | Office | 57 | 45 | $53.46 | $3,047 |
| 99215 Office E&M - Established | Office | 54 | 47 | $111.74 | $6,034 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 48 | 24 | $27.32 | $1,311 |
| 99231 Hospital E&M - Subsequent | Facility | 45 | 15 | $36.48 | $1,642 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 43 | 33 | $37.88 | $1,629 |
By year: 2022 $225K for 3,277 services; 2023 $207K for 3,076 services; 2024 $155K for 2,545 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 122 | 73 | $3.41 | $416 |
Medicare prescription drug claims, 2024
In 2024, the drug Carmelo C Mendiola prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,002 prescriptions and refills. In total Carmelo C Mendiola wrote 26,876 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,002 | 2,688 | 274 | $13K |
| Levothyroxine Sodium Generic | 896 | 2,273 | 209 | $11K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 881 | 881 | 139 | $17K |
| Rosuvastatin Calcium Generic | 822 | 2,147 | 219 | $17K |
| Gabapentin Generic | 776 | 1,121 | 137 | $10K |
| Omeprazole Generic | 662 | 1,645 | 174 | $7,988 |
| Pantoprazole Sodium Generic | 633 | 1,471 | 167 | $6,949 |
| Carvedilol Generic | 608 | 1,496 | 157 | $6,793 |
| Lisinopril Generic | 555 | 1,364 | 136 | $4,989 |
| Clonazepam Generic | 545 | 556 | 68 | $2,440 |
| Amlodipine Besylate Generic | 544 | 1,403 | 148 | $4,461 |
| Metformin Hcl Generic | 532 | 1,363 | 141 | $5,568 |
| Losartan Potassium Generic | 518 | 1,299 | 137 | $6,879 |
| Eliquis Apixaban | 409 | 571 | 71 | $334K |
| Calcitriol Generic | 394 | 821 | 105 | $6,527 |
Brand drugs: 3,556 claims; generic drugs: 23,124 claims; opioid claims: 1,548.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carmelo C Mendiola $1,009 ($1,009 in general payments such as food, travel and fees) from 15 companies. The largest payer was OPKO Pharmaceuticals, LLC with $270.
| Company | Payments | Amount |
|---|---|---|
| OPKO Pharmaceuticals, LLC | 32 | $270 |
| GlaxoSmithKline, LLC. GSK | 13 | $246 |
| Novo Nordisk Inc NVO | 9 | $163 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $63.39 |
| Exact Sciences Corporation EXAS | 2 | $35.15 |
| Amgen Inc. AMGN | 2 | $29.86 |
| Merck Sharp & Dohme LLC MRK | 1 | $28.37 |
| Akebia Therapeutics Inc AKBA | 1 | $25.81 |
| Almatica Pharma LLC | 1 | $24.2 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $22.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.